Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Syncope, Vasovagal D019462 1 associated lipids
Pseudolymphoma D019310 1 associated lipids
Achondroplasia D000130 1 associated lipids
Leishmaniasis, Mucocutaneous D007897 1 associated lipids
Tracheobronchomalacia D055089 1 associated lipids
Trismus D014313 1 associated lipids
Pneumocystis Infections D016720 1 associated lipids
Reproductive Tract Infections D060737 1 associated lipids
Corneal Endothelial Cell Loss D055954 1 associated lipids
Male Urogenital Diseases D052801 1 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
Martin DH et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. 1992 N. Engl. J. Med. pmid:1325036
Gingras BA and Jensen JB Activity of azithromycin (CP-62,993) and erythromycin against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro. 1992 Am. J. Trop. Med. Hyg. pmid:1326232
Pajukanta R et al. In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans. 1992 Antimicrob. Agents Chemother. pmid:1329617
Bonnet M and Van der Auwera P In vitro and in vivo intraleukocytic accumulation of azithromycin (CP-62, 993) and its influence on ex vivo leukocyte chemiluminescence. 1992 Antimicrob. Agents Chemother. pmid:1329619
Cynamon MH and Klemens SP Activity of azithromycin against Mycobacterium avium infection in beige mice. 1992 Antimicrob. Agents Chemother. pmid:1329622
Ballow CH and Amsden GW Azithromycin: the first azalide antibiotic. 1992 Ann Pharmacother pmid:1330097
Nilsen A et al. A double blind study of single dose azithromycin and doxycycline in the treatment of chlamydial urethritis in males. 1992 Genitourin Med pmid:1330880
Jones AB and Herbert CM The in vitro profile of selected 14-membered azalides. 1992 J. Antibiot. pmid:1334956
Frank MO et al. In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes. 1992 Antimicrob. Agents Chemother. pmid:1336337
O'Reilly T et al. Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin. 1992 Antimicrob. Agents Chemother. pmid:1336342
Lazarova Z et al. Azithromycin (Sumamed-Pliva) in the treatment of chlamydial genital tract infections in infertile marriages. 1992 Nov-Dec Int J STD AIDS pmid:1337473
Farthing C et al. Azithromycin for cerebral toxoplasmosis. 1992 Lancet pmid:1346707
Payton S et al. Drug discovery targeted to the Alzheimer's APP mRNA 5'-untranslated region: the action of paroxetine and dimercaptopropanol. 2003 J. Mol. Neurosci. pmid:14501007
Arrieta A et al. High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media. 2003 Antimicrob. Agents Chemother. pmid:14506028
Pichichero ME et al. Azithromycin for the treatment of pertussis. 2003 Pediatr. Infect. Dis. J. pmid:14515842
Saiman L et al. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. 2003 JAMA pmid:14519709
Odemis E et al. Azithromycin-induced leukocytoclastic vasculitis. 2003 J. Rheumatol. pmid:14528532
Jennings MB et al. Comparison of azithromycin and cefadroxil for the treatment of uncomplicated skin and skin structure infections. 2003 Cutis pmid:14533837
Adachi JA et al. Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico. 2003 Clin. Infect. Dis. pmid:14557959
Szpakowski M and Szawłowski A [Azithromycin (Sumamed) administration in empiric treatment of nosocomial pneumonia in upper digestive tract cancer patients]. 2003 Prz. Lek. pmid:14575010
Callaghan R and Allen M Mycobacterium malmoense infection of the knee. 2003 Ann. Rheum. Dis. pmid:14583565
Niederman MS [Conservative use of antibiotics is important, but: "Resistance hysteria is exaggerated"]. 2003 MMW Fortschr Med pmid:14584217
Cotter CJ and Bierne JC Azithromycin for odontogenic infection. 2003 J. Oral Maxillofac. Surg. pmid:14586869
Mecaskey JW et al. The possibility of eliminating blinding trachoma. 2003 Lancet Infect Dis pmid:14592604
Lobzin IuV et al. [New achievements in the diagnosis and treatment of disseminated urogenital chlamydiosis]. 2003 Vestn. Akad. Med. Nauk SSSR pmid:14598508
Farley TA et al. The acceptability and behavioral effects of antibiotic prophylaxis for syphilis prevention. 2003 Sex Transm Dis pmid:14603093
Nafar M et al. A comparison between the efficacy of systemic and local azithromycin therapy in treatment of cyclosporine induced gingival overgrowth in kidney transplant patients. 2003 Transplant. Proc. pmid:14612094
Plouffe JF et al. Azithromycin in the treatment of Legionella pneumonia requiring hospitalization. 2003 Clin. Infect. Dis. pmid:14614670
Matsunaga N et al. A case of QT-interval prolongation precipitated by azithromycin. 2003 N. Z. Med. J. pmid:14615808
Purkins L et al. No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteers. 2003 Br J Clin Pharmacol pmid:14616411
Imbert P et al. Eradication of multiresistant Salmonella Hadar convalescent-phase carriage with azithromycin. 2003 Clin. Microbiol. Infect. pmid:14616738
Owen WM et al. Efficacy of azithromycin for the treatment of feline chlamydophilosis. 2003 J. Feline Med. Surg. pmid:14623199
Mandić Z et al. Electrochemical oxidation of azithromycin and its derivatives. 2003 J Pharm Biomed Anal pmid:14623590
Muhlestein JB Antibiotic treatment of atherosclerosis. 2003 Curr. Opin. Lipidol. pmid:14624138
Theaudin M et al. [Extensive toxoplasmic retinochoroiditis. Diagnostic and therapeutic management]. 2003 J Fr Ophtalmol pmid:14631276
Song Z and Wang C Ultrasensitive assay of azithromycin in medicine and bio-fluids based on its enhanced luminol-H(2)O(2) chemiluminescence reaction using flow injection technique. 2003 Bioorg. Med. Chem. pmid:14642581
Schriever C et al. Red wine, resveratrol, Chlamydia pneumoniae and the French connection. 2003 Atherosclerosis pmid:14644410
Schilling F [Chronic recurrent multifocal osteomyelitis. Opinion exchange concerning the article by T. Seidl et al in Der Orthopäde (2003) 32:535-540]. 2003 Orthopade pmid:14655012
Dobbin CJ and Bye PT Adults with cystic fibrosis: meeting the challenge! 2003 Intern Med J pmid:14656234
Korppi M Community-acquired pneumonia in children: issues in optimizing antibacterial treatment. 2003 Paediatr Drugs pmid:14658923
Nieuwenhuis RF et al. Unusual presentation of early lymphogranuloma venereum in an HIV-1 infected patient: effective treatment with 1 g azithromycin. 2003 Sex Transm Infect pmid:14663119
Derelle J [Anti-inflammatory therapy in cystic fibrosis]. 2003 Arch Pediatr pmid:14671937
Bernstein JM The farmer and the tractor. 2003 Mar-Apr Skinmed pmid:14673307
Lederman HM et al. Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion. 2003 J. Infect. Dis. pmid:14673757
Aihara Y et al. Stevens-Johnson syndrome associated with azithromycin followed by transient reactivation of herpes simplex virus infection. 2004 Allergy pmid:14674950
Enomoto T et al. [Azithromycin therapy for patients with intractable diffuse panbronchiolitis]. 2003 Jpn J Antibiot pmid:14679738
Tateda K et al. [Effects of azithromycin on pathogenic bacteria]. 2003 Jpn J Antibiot pmid:14679740
Shimizu T et al. [Effect of azithromycin on mucus secretion from nasal epithelium]. 2003 Jpn J Antibiot pmid:14679741
Taira M et al. [Effect of azithromycin on Cl ion transport in airway epithelial cells]. 2003 Jpn J Antibiot pmid:14679742
Sakata N et al. [Influence of clarithromycin and azithromycin on cell cycle of neoplasms]. 2003 Jpn J Antibiot pmid:14679743
Bowler SD Effect of long-term treatment with azithromycin on disease parameters in cystic fibrosis. 2003 Jpn J Antibiot pmid:14679744
Inoue K et al. Effects of eight antibacterial agents on cell survival and expression of epithelial-cell- or cell-adhesion-related genes in human gingival epithelial cells. 2004 J. Periodont. Res. pmid:14687228
Kumaresan JA and Mecaskey JW The global elimination of blinding trachoma: progress and promise. 2003 Am. J. Trop. Med. Hyg. pmid:14692677
Malhotra M et al. Ciprofloxacin-tinidazole combination, fluconazole- azithromicin-secnidazole-kit and doxycycline- metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial. 2003 Indian J Med Sci pmid:14701947
Mak DB et al. Control of genital chlamydial infection in the Kimberley region of Western Australia. 2004 Med. J. Aust. pmid:14709130
Putnam SD et al. Antimicrobial susceptibility trends in Campylobacter jejuni and Campylobacter coli isolated from a rural Egyptian pediatric population with diarrhea. 2003 Diagn. Microbiol. Infect. Dis. pmid:14711482
Wolter JM et al. Macrolides in cystic fibrosis: is there a role? 2002 Am J Respir Med pmid:14720043
Gandhi R et al. Pharmacokinetic evaluation of an azithromycin controlled release dosage form in healthy human volunteers: a single dose study. 2004 Int J Pharm pmid:14726116
Liao CH et al. Nutritionally variant streptococcal infections at a University Hospital in Taiwan: disease emergence and high prevalence of beta-lactam and macrolide resistance. 2004 Clin. Infect. Dis. pmid:14727223
Ortega E et al. Modification of phagocytosis and cytokine production in peritoneal and splenic murine cells by erythromycin A, azithromycin and josamycin. 2004 J. Antimicrob. Chemother. pmid:14729765
Aktan B et al. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion. 2003 Nov-Dec Pol J Pharmacol pmid:14730107
Tiukinhoy SD et al. Novel echogenic drug-immunoliposomes for drug delivery. 2004 Invest Radiol pmid:14734925
McLean CA et al. The emergence of Neisseria gonorrhoeae with decreased susceptibility to Azithromycin in Kansas City, Missouri, 1999 to 2000. 2004 Sex Transm Dis pmid:14743069
Asakura E et al. Azithromycin reverses anticancer drug resistance and modifies hepatobiliary excretion of doxorubicin in rats. 2004 Eur. J. Pharmacol. pmid:14744620
Gordon EM and Blumer JL Rationale for single and high dose treatment regimens with azithromycin. 2004 Pediatr. Infect. Dis. J. pmid:14770072
Arguedas A et al. Single dose azithromycin for the treatment of uncomplicated otitis media. 2004 Pediatr. Infect. Dis. J. pmid:14770073
Arrieta A and Singh J Management of recurrent and persistent acute otitis media: new options with familiar antibiotics. 2004 Pediatr. Infect. Dis. J. pmid:14770074
Cohen R Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis. 2004 Pediatr. Infect. Dis. J. pmid:14770076
Ruuskanen O Safety and tolerability of azithromycin in pediatric infectious diseases: 2003 update. 2004 Pediatr. Infect. Dis. J. pmid:14770077
Klein JO and Schaad UB [Use of azithromycin in the treatment of acute otitis media and tonsillopharyngitis: summary and conclusions. 2004 Pediatr. Infect. Dis. J. pmid:14770078
Gross M et al. Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor. 2004 J. Antimicrob. Chemother. pmid:14963065
Hartmann M [Therapy of syphilis]. 2004 Hautarzt pmid:14968333
Law C and Amsden GW Single-dose azithromycin for respiratory tract infections. 2004 Ann Pharmacother pmid:14970367
Sugie M et al. Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin. 2004 Antimicrob. Agents Chemother. pmid:14982769
Kanazawa S et al. Azithromycin and bronchiolitis obliterans. 2004 Am. J. Respir. Crit. Care Med. pmid:14982826
Chen GF et al. [Follow up of 16 cases with congenital toxoplasmosis treated with azithromycin]. 2004 Zhonghua Er Ke Za Zhi pmid:14990100
Kasahara K et al. Longterm azithromycin therapy for three patients with chronic lower respiratory tract infections. 2004 J. Infect. Chemother. pmid:14991517
Lin L et al. A retrospective study on clinical features of and treatment methods for 77 severe cases of SARS. 2003 Am. J. Chin. Med. pmid:14992536
McCall KL et al. Determination of the lack of a drug interaction between azithromycin and warfarin. 2004 Pharmacotherapy pmid:14998219
Carfartan G et al. Effect of subinhibitory concentrations of azithromycin on adherence of Pseudomonas aeruginosa to bronchial mucins collected from cystic fibrosis patients. 2004 J. Antimicrob. Chemother. pmid:14998983
Ables AZ and Warren PK High-dose azithromycin or amoxicillin-clavulanate for recurrent otitis media? 2004 J Fam Pract pmid:15000920
Suskova VS et al. [Immuno-modulating properties of a macrolide antibiotic "Z-factor"]. 2003 Antibiot. Khimioter. pmid:15002174
Pisarev VV et al. [Comparative study of azithromycin pharmacokinetics in healthy volunteers in open cross randomized procedure]. 2003 Antibiot. Khimioter. pmid:15004973
Capitano B et al. Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults. 2004 Chest pmid:15006955
Abe T et al. [A case of Q fever infection causing acute exacerbation of chronic respiratory failure]. 2004 Nihon Kokyuki Gakkai Zasshi pmid:15007923
Chand DH et al. Trial of metronidazole vs. azithromycin for treatment of cyclosporine-induced gingival overgrowth. 2004 Pediatr Transplant pmid:15009842
Azithromycin treatment failures in syphilis infections--San Francisco, California, 2002-2003. 2004 MMWR Morb. Mortal. Wkly. Rep. pmid:15017376
Ngan CC et al. Susceptibility testing of Singapore strains of Mycoplasma hominis to tetracycline, gatifloxacin, moxifloxacin, ciprofloxacin, clindamycin, and azithromycin by the Etest method. 2004 Diagn. Microbiol. Infect. Dis. pmid:15023431
Máiz Carro L and Cantón Moreno R [Azithromycin therapy in cystic fibrosis]. 2004 Med Clin (Barc) pmid:15030744
Frenck RW et al. Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents. 2004 Clin. Infect. Dis. pmid:15034826
Smelov V et al. Azithromycin treatment follow-up: antibacterial susceptibility of Chlamydia trachomatis in patients with chronic prostatitis. 2004 Int. J. Antimicrob. Agents pmid:15037332
Manavi K et al. The prevalence of rectal chlamydial infection amongst men who have sex with men attending the genitourinary medicine clinic in Edinburgh. 2004 Int J STD AIDS pmid:15038860
Baumann U et al. Long term azithromycin therapy in cystic fibrosis patients: a study on drug levels and sputum properties. 2004 Can. Respir. J. pmid:15045047
Miron D et al. Azithromycin as an alternative to nalidixic acid in the therapy of childhood shigellosis. 2004 Pediatr. Infect. Dis. J. pmid:15071299
Palcevski G et al. Antibiotic use profile at paediatric clinics in two transitional countries. 2004 Pharmacoepidemiol Drug Saf pmid:15072118
Habib AR and Fernando R Efficacy of azithromycin 1g single dose in the management of uncomplicated gonorrhoea. 2004 Int J STD AIDS pmid:15075017
Sopena N et al. Comparative study of the efficacy and tolerance of azithromycin versus clarithromycin in the treatment of community-acquired pneumonia in adults. 2004 J Chemother pmid:15078008
Rao KB et al. Enhanced hypoprothrombinemia with warfarin due to azithromycin. 2004 Ann Pharmacother pmid:15084685
Wenzler S et al. Comparative in vitro activities of three new quinolones and azithromycin against aerobic pathogens causing respiratory tract and abdominal wound infections. 2004 Chemotherapy pmid:15084805
Paik JW et al. Inhibition of cyclosporin A-induced gingival overgrowth by azithromycin through phagocytosis: an in vivo and in vitro study. 2004 J. Periodontol. pmid:15088875